Did you miss January 2013's event?
|Were you not able to attend our prior 2nd Enhancing Drug Bioavailability & Solubility event that took place on January 21-23, 2013? Click here to access a summary of the event highlighting the key takeaways.|
As increased numbers of compounds are brought forward for development, improving drug solubility and enhancing bioavailability remains a critical challenge within formulation development. The solubility issues complicating the delivery of new drugs also affect the delivery of many existing drugs.
Based on the successes of our Enhancing Drug Bioavailability and Solubility Conference Series, ExL Pharma brings together the industry’s leading formulation experts together to share and discuss emerging drug bioavailability and solubility enhancement strategies. Learn from the industry's most accomplished drug formulation and preformulation experts. Attend to hear and discuss unique take-home examples, case studies and multiple formulation and preformulation strategies, which will assist in improving drug solubility and bioavailability, maximizing exposure, and reducing time-to-market on current and future drug products. This intensive 3-Day program will enable you to gain novel drug solubility strategies that will benefit your current and future pipelines.
What’s new for 2014?
Key program sessions include:
And many more...
Benefit from industry participation from Pfizer, Merck, Novartis, Bristol Myers Squibb, Amgen, GlaxoSmithKline, Roche, Boehringer Ingelheim, Celgene, Eli Lilly, Millennium Pharmaceuticals, Vertex Pharmaceuticals, Genzyme, AstraZeneca, Alcon Labs, and many more drug solubility, bioavailability and delivery experts. Additionally, do not miss keynote, Stephen Byrn (Purdue University) and Chris Benmore (Argonne National Laboratory) discuss innovations in levitation technology for the production of amorphous drugs.
“Very good examples provided. Great explanations to questions raised!”
- Associate Director, Pharmaceutical Science,Takeda
“A very well organized event!”
- Scientist, DMPK, Lexicon Pharmaceuticals
“By far exceeded expectations! Great floor setup encouraging interaction”
- Product Specialist, Pion, Inc.
This conference is specifically designed for pharmaceutical, biotech and academic professionals specializing in: